Schonfeld Strategic Advisors »

Atea Pharmaceuticals shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $164k 46k 3.57
2021-09-30 $3.7M 104k 35.06

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr China Lg-cap Etf (FXI)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Schonfeld Strategic Advisors

Top funds holding Atea Pharmaceuticals

BlackRock
BML Capital Management
FMR
Tang Capital Management
Vanguard Group
Bain Capital Life Sciences Investors
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Acadian Asset Management
Renaissance Technologies
Two Sigma Advisers
Jpmorgan Chase & Co
Charles Schwab Investment Management
Northern Trust

View all funds holding Atea Pharmaceuticals